| [1] |
Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu.
Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
|
| [2] |
Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong.
Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023)
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431.
|
| [3] |
An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui.
Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438.
|
| [4] |
Yang Haixia, Zhang Xiaoyan, Huang Yi, Li Qiu.
Effective and safety of concurrent intensity-modulated radiotherapy and anti-tuberculosis chemotherapy in patients with active pulmonary tuberculosis comorbid with thoracic tumor
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 312-321.
|
| [5] |
Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Inspire-CODA Research Group.
Expert consensus on the treatment of tuberculosis with contezolid
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 123-129.
|
| [6] |
Li Xuelian, Zhang Hongyan, Wang Jun, Wang Qingfeng, Ma Liping, Chu Naihui, Nie Wenjuan.
Safety of extended delamanid use in drug-resistant tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 164-168.
|
| [7] |
Wang Dafu, Ma Xiaoxue, Wang Yun, Li Fudong, Rao Wen, Gong Tingting, Li Shijun, Li Jinlan.
Analysis of risk factors for patient delay and adverse treatment outcomes among patients with pulmonary tuberculosis and diabetes mellitus in Guizhou Province, 2016—2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 201-209.
|
| [8] |
Li Fudong, Ma Xiaoxue, Zhou Jian, Wang Dafu, Zhang Yueying, Gong Tingting, Rao Wen, Hong Feng, Li Shijun, Li Jinlan.
Characteristics and treatment outcome analysis of MTB/HIV dual infection patients in Guizhou Province from 2018 to 2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 36-43.
|
| [9] |
Shi Yilin, Gu Yan.
Meta-analysis of the efficacy, adverse reactions, and fatality rate of glucocorticoid combined with anti-tuberculosis drugs in the treatment of tuberculous serositis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 77-86.
|
| [10] |
Fan Jun, Wang Heng, Lan Tinglong, Dong Weijie, Tang Kai, Li Yuan, Yan Guangxuan, Xu Shangsheng, Kang Zhigang, Qin Shibing.
Clinical characteristics and surgical outcomes of 12 cases of non-tuberculous mycobacterial spondylitis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 87-95.
|
| [11] |
Ye Zhiteng, Ren Fei, Wang Hua, Yang Ming, Chen Yu, Chen Xiaohong, Wang Yun, Fan Lin.
Treatment outcomes and influencing factors in elderly patients with multidrug/rifampicin-resistant pulmonary tuberculosis: a national multicenter, retrospective cohort study
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1023-1029.
|
| [12] |
Huang Tao, Jian Huiyong, Wang Xinqi, Liu Nianqiang, Yipar Aihaiti, Wang Mingzhe, Jiayinati Jingesi, Wang Senlu.
Analysis of influencing factors of treatment outcomes in patients with pulmonary tuberculosis complicated with diabetes mellitus in Xinjiang Uygur Autonomous Region
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1083-1088.
|
| [13] |
Shi Lulu, Jing Hui, Liang Min, Li Xuezheng.
Analysis of clinical results of blood concentration detection of antituberculosis drugs by liquid chromatography-tandem mass spectrometry
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 886-891.
|
| [14] |
Liu Siyuan, Cun Xinhua, Wu Lei, Bai Ping, Zhou Yi, Rao Tao, Chen Lin, Dou Jichen, Zhao Heng, Wang Yizhou.
Application of individualized 3D printed artificial vertebral body replacement in reconstruction of complex tuberculosis-affected spine
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 918-925.
|
| [15] |
Ye Zhiteng, Ren Fei, Wang Hua, Yang Ming, Chen Yu, Chen Xiaohong, Wang Yun, Fan Lin.
Analysis of influencing factors of treatment outcomes of retreated multidrug-resistant/rifampicin-resistant pulmonary tuberculosis patients: a national multicenter retrospective cohort study
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 778-784.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
